Goldman Sachs
KNSA icon

Goldman Sachs’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.6M Buy
383,668
+227,340
+145% +$6.29M ﹤0.01% 2230
2025
Q1
$3.47M Sell
156,328
-54,859
-26% -$1.22M ﹤0.01% 2994
2024
Q4
$4.18M Sell
211,187
-297,186
-58% -$5.88M ﹤0.01% 2986
2024
Q3
$12.7M Buy
+508,373
New +$12.7M ﹤0.01% 2071
2024
Q2
Sell
-760,107
Closed -$15M 4840
2024
Q1
$15M Sell
760,107
-149,105
-16% -$2.94M ﹤0.01% 1741
2023
Q4
$15.9M Buy
909,212
+43,430
+5% +$762K ﹤0.01% 1742
2023
Q3
$15M Buy
865,782
+494,264
+133% +$8.59M ﹤0.01% 1694
2023
Q2
$5.23M Sell
371,518
-50,415
-12% -$710K ﹤0.01% 2533
2023
Q1
$4.54M Sell
421,933
-593,975
-58% -$6.39M ﹤0.01% 2619
2022
Q4
$15.2M Buy
1,015,908
+110,640
+12% +$1.66M ﹤0.01% 1816
2022
Q3
$11.6M Buy
905,268
+271,364
+43% +$3.48M ﹤0.01% 2016
2022
Q2
$6.14M Sell
633,904
-302,700
-32% -$2.93M ﹤0.01% 2494
2022
Q1
$9.31M Buy
936,604
+357,387
+62% +$3.55M ﹤0.01% 2300
2021
Q4
$6.82M Buy
579,217
+89,644
+18% +$1.06M ﹤0.01% 2567
2021
Q3
$5.58M Buy
489,573
+65,877
+16% +$750K ﹤0.01% 2714
2021
Q2
$5.9M Sell
423,696
-1,465
-0.3% -$20.4K ﹤0.01% 2657
2021
Q1
$7.87M Sell
425,161
-134,049
-24% -$2.48M ﹤0.01% 2371
2020
Q4
$9.88M Buy
559,210
+444,853
+389% +$7.86M ﹤0.01% 2066
2020
Q3
$1.75M Buy
114,357
+30,229
+36% +$463K ﹤0.01% 2976
2020
Q2
$2.14M Buy
84,128
+61,431
+271% +$1.57M ﹤0.01% 2802
2020
Q1
$351K Buy
22,697
+9,154
+68% +$142K ﹤0.01% 3670
2019
Q4
$150K Sell
13,543
-45,091
-77% -$499K ﹤0.01% 4062
2019
Q3
$499K Buy
58,634
+44,601
+318% +$380K ﹤0.01% 3596
2019
Q2
$190K Sell
14,033
-3,436
-20% -$46.5K ﹤0.01% 3890
2019
Q1
$315K Buy
+17,469
New +$315K ﹤0.01% 3725
2018
Q3
Sell
-90,090
Closed -$1.56M 4186
2018
Q2
$1.56M Buy
+90,090
New +$1.56M ﹤0.01% 2989